SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy

Cellular Physiology and Biochemistry

Volumn 37, Issue 2, 2015, Pages 603-614

  Voelkl, Jakob ^a   Castor, Tatsiana ^a   Musculus, Katharina ^a   Viereck, Robert ^a   Mia, Sobuj ^a   Feger, Martina ^a   Alesutan, Ioana ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acta1; Cardiac hypertrophy; HL 1 cardiomyocytes; Isoproterenol; p27; SGK1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; ISOPRENALINE; MESSENGER RNA; MOLECULAR MARKER; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; CDKN1B PROTEIN, MOUSE; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; SERUM-GLUCOCORTICOID REGULATED KINASE;

ANIMAL EXPERIMENT; AORTA CONSTRICTION; ARTICLE; CELL SIZE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; HEART HYPERTROPHY; HEART MUSCLE CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; CARDIOMEGALY; CELL LINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION; IMMEDIATE-EARLY PROTEINS; MALE; MICE; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 84941255120     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430380     Document Type: Article

References (52)

1. Petriz BA, Franco OL: Effects of hypertension and exercise on cardiac proteome remodelling. Biomed Res Int 2014;2014:634132.
2. Nichtova Z, Novotova M, Kralova E, Stankovicova T: Morphological and functional characteristics of models of experimental myocardial injury induced by isoproterenol. Gen Physiol Biophys 2012;31:141-151.
3. Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A: Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 2005;111:1652-1659.
4. Das S, Aiba T, Rosenberg M, Hessler K, Xiao C, Quintero PA, Ottaviano FG, Knight AC, Graham EL, Bostrom P, Morissette MR, del Monte F, Begley MJ, Cantley LC, Ellinor PT, Tomaselli GF, Rosenzweig A: Pathological role of serum-and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation 2012;126:2208-2219.
5. Voelkl J, Lin Y, Alesutan I, Ahmed MS, Pasham V, Mia S, Gu S, Feger M, Saxena A, Metzler B, Kuhl D, Pichler BJ, Lang F: Sgk1 sensitivity of Na(+)/H(+) exchanger activity and cardiac remodeling following pressure overload. Basic Res Cardiol 2012;107:236.
6. Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross J, Jr., Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D, Lang F: SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med 2006;84:396-404.
7. Firestone GL, Giampaolo JR, O'Keeffe BA: Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 2003;13:1-12.
8. McCormick JA, Bhalla V, Pao AC, Pearce D: SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology (Bethesda) 2005;20:134-139.
9. Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S: Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A 2000;97:8157-8162.
10. Alessi DR, Cohen P: Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998;8:55-62.
11. Lu M, Wang J, Ives HE, Pearce D: mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel. J Biol Chem 2011;286:30647-30654.
12. Gleason CE, Frindt G, Cheng CJ, Ng M, Kidwai A, Rashmi P, Lang F, Baum M, Palmer LG, Pearce D: mTORC2 regulates renal tubule sodium uptake by promoting ENaC activity. J Clin Invest 2015;125:117-128.
13. Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM: mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 2008;30:701-711.
14. Feng Y, Wang Q, Wang Y, Yard B, Lang F: SGK1-mediated fibronectin formation in diabetic nephropathy. Cell Physiol Biochem 2005;16:237-244.
15. Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F: h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 1999;116:1081-1088.
16. Damilano F, Perino A, Hirsch E: PI3K kinase and scaffold functions in heart. Ann NY Acad Sci 2010;1188:39-45.
17. Voelkl J, Mia S, Meissner A, Ahmed MS, Feger M, Elvira B, Walker B, Alessi DR, Alesutan I, Lang F: PKB/SGKresistant GSK-3 signaling following unilateral ureteral obstruction. Kidney Blood Press Res 2013;38:156-164.
18. Voelkl J, Pasham V, Ahmed MS, Walker B, Szteyn K, Kuhl D, Metzler B, Alesutan I, Lang F: Sgk1-dependent stimulation of cardiac Na+/H+ exchanger Nhe1 by dexamethasone. Cell Physiol Biochem 2013;32:25-38.
19. Yang M, Zheng J, Miao Y, Wang Y, Cui W, Guo J, Qiu S, Han Y, Jia L, Li H, Cheng J, Du J: Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012;32:1675-1686.
20. Fliegel L: Regulation of the Na(+)/H(+) exchanger in the healthy and diseased myocardium. Expert Opin Ther Targets 2009;13:55-68.
21. Xue J, Mraiche F, Zhou D, Karmazyn M, Oka T, Fliegel L, Haddad GG: Elevated myocardial Na+/H+ exchanger isoform 1 activity elicits gene expression that leads to cardiac hypertrophy. Physiol Genomics 2010;42:374-383.
22. Mohamed IA, Gadeau AP, Fliegel L, Lopaschuk G, Mlih M, Abdulrahman N, Fillmore N, Mraiche F: Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy. PLoS One 2015;10:e0123318.
23. Schmid E, Xuan NT, Zahir N, Russo A, Yang W, Kuhl D, Faggio C, Shumilina E, Lang F: Serum-and glucocorticoid-inducible kinase 1 sensitive NF-kappaB signaling in dendritic cells. Cell Physiol Biochem 2014;34:943-954.
24. Hauck L, Harms C, An J, Rohne J, Gertz K, Dietz R, Endres M, von Harsdorf R: Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med 2008;14:315-324.
25. Hinrichsen R, Haunso S, Busk PK: Different regulation of p27 and Akt during cardiomyocyte proliferation and hypertrophy. Growth Factors 2007;25:132-140.
26. Motti ML, De Marco C, Califano D, Fusco A, Viglietto G: Akt-dependent T198 phosphorylation of cyclindependent kinase inhibitor p27kip1 in breast cancer. Cell Cycle 2004;3:1074-1080.
27. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002;8:1136-1144.
28. Su M, Wang J, Wang C, Wang X, Dong W, Qiu W, Wang Y, Zhao X, Zou Y, Song L, Zhang L, Hui R: MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ 2015;22:986-999.
29. Kang L, Ge CJ, Hu SJ: Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats. Pharmacology 2007;80:120-126.
30. Li JM, Brooks G: Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy. Am J Physiol 1997;273:H1358-1367.
31. Konecny F, Zou J, Husain M, von Harsdorf R: Post-myocardial infarct p27 fusion protein intravenous delivery averts adverse remodelling and improves heart function and survival in rodents. Cardiovasc Res 2012;94:492-500.
32. Yu L, Quinn DA, Garg HG, Hales CA: Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 2008;177:1276-1284.
33. Poolman RA, Li JM, Durand B, Brooks G: Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res 1999;85:117-127.
34. Eylenstein A, Gehring EM, Heise N, Shumilina E, Schmidt S, Szteyn K, Munzer P, Nurbaeva MK, Eichenmuller M, Tyan L, Regel I, Foller M, Kuhl D, Soboloff J, Penner R, Lang F: Stimulation of Ca2+-channel Orai1/STIM1 by serum-and glucocorticoid-inducible kinase 1 (SGK1). FASEB J 2011;25:2012-2021.
35. Towhid ST, Liu GL, Ackermann TF, Beier N, Scholz W, Fuchss T, Toulany M, Rodemann HP, Lang F: Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683. Cell Physiol Biochem 2013;32:838-848.
36. Voelkl J, Alesutan I, Pakladok T, Viereck R, Feger M, Mia S, Schonberger T, Noegel AA, Gawaz M, Lang F: Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling. Biochem Biophys Res Commun 2014;445:244-249.
37. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, Richter K, Jansen M, Schlunz M, Klingel K, Loffing J, Kauselmann G, Bosl MR, Lang F, Kuhl D: Impaired renal Na(+) retention in the sgk1-knockout mouse. J Clin Invest 2002;110:1263-1268.
38. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J, Jr., Chien KR: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A 1991;88:8277-8281.
39. Feger M, Mia S, Pakladok T, Nicolay JP, Alesutan I, Schneider SW, Voelkl J, Lang F: Down-regulation of renal klotho expression by Shiga toxin 2. Kidney Blood Press Res 2014;39:441-449.
40. Alesutan I, Feger M, Pakladok T, Mia S, Ahmed MS, Voelkl J, Lang F: 25-Hydroxyvitamin D3 1-alphahydroxylase-dependent stimulation of renal klotho expression by spironolactone. Kidney Blood Press Res 2013;37:475-487.
41. Fang X, Robinson J, Wang-Hu J, Jiang L, Freeman DA, Rivkees SA, Wendler CC: Cyclic AMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes. Am J Physiol Cell Physiol 2015;10.1152/ ajpcell.00058.2015ajpcell 00058 02015.
42. Feger M, Fajol A, Lebedeva A, Meissner A, Michael D, Voelkl J, Alesutan I, Schleicher E, Reichetzeder C, Hocher B, Qadri SM, Lang F: Effect of carbon monoxide donor CORM-2 on vitamin D3 metabolism. Kidney Blood Press Res 2013;37:496-505.
43. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA: Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 1999;18:3024-3033.
44. Burton PB, Yacoub MH, Barton PJ: Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J 1999;20:604-611.
45. Smith MA, Zhu X, Lee HG, Harris PL, Fortino AE, Perry G, Castellani RJ: Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy. Age (Dordr) 2006;28:85-91.
46. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193-199.
47. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM: RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci U S A 2009;106:9268-9273.
48. Schiappacassi M, Lovisa S, Lovat F, Fabris L, Colombatti A, Belletti B, Baldassarre G: Role of T198 modification in the regulation of p27(Kip1) protein stability and function. PLoS One 2011;6:e17673.
49. Zhao D, Besser AH, Wander SA, Sun J, Zhou W, Wang B, Ince T, Durante MA, Guo W, Mills G, Theodorescu D, Slingerland J: Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene 2015;10.1038/onc.2014.473
50. Wyatt AW, Hussain A, Amann K, Klingel K, Kandolf R, Artunc F, Grahammer F, Huang DY, Vallon V, Kuhl D, Lang F: DOCA-induced phosphorylation of glycogen synthase kinase 3beta. Cell Physiol Biochem 2006;17:137-144.
51. Mraiche F, Fliegel L: Elevated expression of activated Na(+)/H (+) exchanger protein induces hypertrophy in isolated rat neonatal ventricular cardiomyocytes. Mol Cell Biochem 2011;358:179-187.
52. Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML: Angiotensin type 1 receptor mediates thyroid hormoneinduced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res Cardiol 2009;104:653-667.